Original research: Flavophospholipol: Effect on multi-drug resistant Salmonella enterica serovar typhimurium in swine

Journal of Swine Health and Production

Volumn 17, Issue 6, 2009, Pages 308-317

  Dorr, Paul M ^a   Gebreyes, Wondwossen A ^b  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Antimicrobial resistance; Flavophospholipol; Salmonella serovar typhimurium; Swine

Indexed keywords

ANIMALIA; SALMONELLA; SALMONELLA ENTERICA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; SALMONELLA TYPHIMURIUM; SUIDAE;

EID: 70749084770     PISSN: 1537209X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. CDC - Foodborne Outbreak Response and Surveillance Unit. US foodborne disease outbreaks. 2002; 2006: 1. Available at: http://www.cdc. gov/foodborneoutbreaks/outbreak-data.htn. Accessed 15 September 2009.
2. Dorr PM, Tadesse DA, Zewde BM, Thakur S, Gebreyes WA. Longitudinal study on Salmonella dispersion and the role of environmental contamination in commercial swine production systems. Appl Environ Microbiol. 2009; 75: l478-l486.
3. Gebreyes WA, Thakur S, Davies PR, Funk JA, Aider C. Trends in antimicrobial resistance, phage types and integrons among Salmonella serotypes from pigs, 1997-2000. J Antimicrob Chemother. 2004: 53: 997-1003.
4. Rostagno MH, McKean JD. Prevalence of Salmonella enterica and Salmonella enterica serotype ryphimurium in swine at slaughter. Proc Res Work Anim Dis Conf. 2006: 439-440.
5. Hurd HS, McKean JD, Griffith RW, Wesley IV, Rostagno MH. Salmonella enterica infections in market swine with and without transport and holding. Appl Environ Microbiol. 2002; 68: 2376-2381.
6. Larsen ST, McKean JD, Hurd HS, Rostagno MH, Griffith RW, Wesley IV. Impact of commercial preharvest transportation and holding on the prevalence of Salmonella enterica in cull sows. J FoodProt. 2003: 66: 1134-1138.
7. Briggs CE, Fratamico PM. Molecular characterization of an antibiotic resistance gene cluster of Salmonella typhimurium DT104. Antimicrob Agents Chemother. 1999: 43: 846-849.
8. Gebreyes WA, Altier C. Molecular characterization of multidrug-resistant Salmonella enterica subsp. enterica serovu: Typhimurium isolates from swine. J Clin Microbiol. 2002: 40: 2813-2822.
9. Kachatourians GG. Agricultural use of antibiotics and the evolution and transfer of antibiotic-resistant bacteria. Can MedAssoc J. 1998: 159: 1129-1136.
10. van den Bogaard AE, Hazen M, Hoyer M, Oostenbach P, Stobberingh E. Effects of flavophospholipol on resistance in fecal Escherichia coli and enterococci of fattening pigs. Antimicrob Agents Chemother. 2002; 46: 1 10-118.
11. Dealy J, Moeller MW. Influence of bambermycins on Salmonella infection and antibiotic resistance in swine. J Anim Sci. 1976: 42: 1331-1336.
12. Pfaller MA. Flavophospholipol use in animals: Positive implications for antimicrobial resistance based on its microbiologic properties. Diagn Microbiol Infect Dis. 2006: 56: 115-121.
13. Loynachan AT, Harris DL. Dose determination for acute Salmonella infection in pigs. Appl Environ Microbiol. 2005: 71: 2753-2755.
14. Hurd HS, GaileyJK, McKean JD, Rostagno MH. Rapid infection in market-weight swine following exposure to a Salmonella typhimuriumcontaminated environment. Am. J. Vet Res. 2001: 62: 1194-1197.
15. National Committee for Clinical Laboratory Standards. Performance standards fir antimicrobial disc and dilution susceptibility tests fir bacteria isolated from animals; approved standard. 2nd ed. M31-A2. Wayne, Pennsylvania: National Committee for Clinical Laboratory Standards; 2002.
16. National Committee for Clinical Laboratory Standards. Performance standards fir antimicrobial susceptibility testing. 12th informational supplement, M 100-S12. Wayne, Pennsylvania: National Committee for Clinical Laboratory Standards; 2002.
17. Gebreyes WA, Davies PR, Morrow WE, Funk JA, Altier C. Antimicrobial resistance of Salmonella isolates from swine. J Clin Microbiol. 2000; 38: 4633-4636.
18. Butaye P, Devriese LA, Haesebrouck F. Influence of different medium components on the in vitro activity of the growth-promoting antibiotic flavomycin against enterococci. J Antimicrob Chemother. 2000; 46: 713-7l6.
19. Jukes TH, DuPont HL, Crawford LM, eds. Antibiotics, Sulfonamides, and Public Health. Boca Raton, Florida: CRC Press, Inc; 1984.
20. Bellido F, Vladoianu IR, Auckenthaler R, Suter S, Wacker P, Then RL, Pechere JC. Permeability and penicillin-binding protein alterations in Salmonella muenchen: Stepwise resistance acquired during beta-lactam therapy. Antimicrob Agents Chemother. 1989: 33: 1113-1115.
21. Medeiros AA, O'Brien TF, Rosenberg EY, Nikaido H. Loss of OmpC porin in a strain of Salmonella typhimurium causes increased resistance to cephalosporins during therapy. J Infect Dis. 1987: 156: 751-757.
22. Girard AE, English AR, Evangelisti DG, Lynch JE, Solomons IA. Influence of subtherapeutic levels of a combination of neomycin and oxytetracydine on Salmonella typhimurium in swine, calves, and chickens. Antimicrob Agents Chemother. 1976: 10: 89-95.